Esperion Therapeutics, Inc. (ESPR)
2.61
0.00 (0.00%)
USD |
NASDAQ |
Apr 02, 16:00
2.62
+0.01
(+0.38%)
After-Hours: 20:00
Esperion Therapeutics Total Assets (Quarterly) : 883.74M for Dec. 31, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Nektar Therapeutics | 280.41M |
| Harrow, Inc. | 405.21M |
| Catalyst Pharmaceuticals, Inc. | 1.107B |
| Rigel Pharmaceuticals, Inc. | 560.62M |
| Karyopharm Therapeutics, Inc. | 117.46M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.186B |
| Shareholders Equity (Quarterly) | -301.96M |
| Debt to Equity Ratio | -1.815 |
| Current Ratio | 1.538 |
| Net Debt Paydown Yield | 0.26% |